

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 5.07202829 |
| 2 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.54827134 |
| 3 | nuclear pore complex assembly (GO:0051292) | 4.50894404 |
| 4 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.32850176 |
| 5 | cellular extravasation (GO:0045123) | 3.96927290 |
| 6 | nuclear pore organization (GO:0006999) | 3.95880897 |
| 7 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.82298502 |
| 8 | neutrophil mediated immunity (GO:0002446) | 3.66280009 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 3.55422161 |
| 10 | iron ion import (GO:0097286) | 3.54866365 |
| 11 | protein targeting to Golgi (GO:0000042) | 3.48981183 |
| 12 | cysteine metabolic process (GO:0006534) | 3.48828572 |
| 13 | neural tube formation (GO:0001841) | 3.48477916 |
| 14 | urea cycle (GO:0000050) | 3.47134767 |
| 15 | urea metabolic process (GO:0019627) | 3.47134767 |
| 16 | mitotic sister chromatid cohesion (GO:0007064) | 3.46947731 |
| 17 | establishment of protein localization to Golgi (GO:0072600) | 3.42750998 |
| 18 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.36792021 |
| 19 | macroautophagy (GO:0016236) | 3.36461790 |
| 20 | pore complex assembly (GO:0046931) | 3.35877463 |
| 21 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.33256394 |
| 22 | response to peptidoglycan (GO:0032494) | 3.33031255 |
| 23 | L-phenylalanine catabolic process (GO:0006559) | 3.27946844 |
| 24 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.27946844 |
| 25 | myeloid leukocyte mediated immunity (GO:0002444) | 3.23782214 |
| 26 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.22993028 |
| 27 | early endosome to late endosome transport (GO:0045022) | 3.22315674 |
| 28 | alpha-linolenic acid metabolic process (GO:0036109) | 3.18836057 |
| 29 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.17722197 |
| 30 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.15215830 |
| 31 | L-phenylalanine metabolic process (GO:0006558) | 3.14497597 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.14497597 |
| 33 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.12599635 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.12125213 |
| 35 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.10721637 |
| 36 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.10721637 |
| 37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.10701547 |
| 38 | protein carboxylation (GO:0018214) | 3.10701547 |
| 39 | histone mRNA catabolic process (GO:0071044) | 3.10096179 |
| 40 | regulation of cholesterol homeostasis (GO:2000188) | 3.06599330 |
| 41 | negative regulation of fibrinolysis (GO:0051918) | 3.05208700 |
| 42 | macrophage activation involved in immune response (GO:0002281) | 3.02602338 |
| 43 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.01357575 |
| 44 | negative regulation of fibroblast apoptotic process (GO:2000270) | 3.00145717 |
| 45 | nitrogen cycle metabolic process (GO:0071941) | 2.95308296 |
| 46 | glutamate metabolic process (GO:0006536) | 2.93676976 |
| 47 | positive regulation by symbiont of host defense response (GO:0052509) | 2.93508273 |
| 48 | modulation by symbiont of host defense response (GO:0052031) | 2.93508273 |
| 49 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.93508273 |
| 50 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.93508273 |
| 51 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.93508273 |
| 52 | modulation by symbiont of host immune response (GO:0052553) | 2.93508273 |
| 53 | hepatocyte apoptotic process (GO:0097284) | 2.93269376 |
| 54 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.92983483 |
| 55 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.92983483 |
| 56 | lysine metabolic process (GO:0006553) | 2.92585155 |
| 57 | lysine catabolic process (GO:0006554) | 2.92585155 |
| 58 | sodium ion export (GO:0071436) | 2.88926724 |
| 59 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.87907572 |
| 60 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.87306891 |
| 61 | aromatic amino acid family catabolic process (GO:0009074) | 2.85557861 |
| 62 | kynurenine metabolic process (GO:0070189) | 2.84799543 |
| 63 | locomotory exploration behavior (GO:0035641) | 2.84790004 |
| 64 | nerve growth factor signaling pathway (GO:0038180) | 2.84767973 |
| 65 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.83721946 |
| 66 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.80668124 |
| 67 | negative regulation of cell killing (GO:0031342) | 2.80668124 |
| 68 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.80565067 |
| 69 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.80056273 |
| 70 | protein targeting to vacuole (GO:0006623) | 2.79649562 |
| 71 | protein targeting to lysosome (GO:0006622) | 2.79649562 |
| 72 | establishment of protein localization to vacuole (GO:0072666) | 2.79649562 |
| 73 | negative regulation of interleukin-12 production (GO:0032695) | 2.79335054 |
| 74 | microglial cell activation (GO:0001774) | 2.79208625 |
| 75 | interkinetic nuclear migration (GO:0022027) | 2.79054432 |
| 76 | macrophage activation (GO:0042116) | 2.78237521 |
| 77 | drug catabolic process (GO:0042737) | 2.76614262 |
| 78 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.76392427 |
| 79 | synaptic vesicle maturation (GO:0016188) | 2.75119344 |
| 80 | glutamate secretion (GO:0014047) | 2.75062159 |
| 81 | protein localization to endosome (GO:0036010) | 2.73242893 |
| 82 | sulfur amino acid catabolic process (GO:0000098) | 2.72981323 |
| 83 | regulation of fibroblast apoptotic process (GO:2000269) | 2.72279004 |
| 84 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.72129905 |
| 85 | cell wall macromolecule catabolic process (GO:0016998) | 2.70674371 |
| 86 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.70313885 |
| 87 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.70313885 |
| 88 | regulation of ARF protein signal transduction (GO:0032012) | 2.69743912 |
| 89 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.69472673 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.65641611 |
| 91 | detection of biotic stimulus (GO:0009595) | 2.63763480 |
| 92 | bile acid biosynthetic process (GO:0006699) | 2.61192476 |
| 93 | N-terminal protein amino acid acetylation (GO:0006474) | 2.60517429 |
| 94 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.60446427 |
| 95 | positive regulation of macroautophagy (GO:0016239) | 2.60401576 |
| 96 | drug transmembrane transport (GO:0006855) | 2.60298155 |
| 97 | regulation of protein activation cascade (GO:2000257) | 2.57557797 |
| 98 | growth hormone receptor signaling pathway (GO:0060396) | 2.57410921 |
| 99 | indole-containing compound catabolic process (GO:0042436) | 2.56764487 |
| 100 | indolalkylamine catabolic process (GO:0046218) | 2.56764487 |
| 101 | tryptophan catabolic process (GO:0006569) | 2.56764487 |
| 102 | positive regulation of lipid catabolic process (GO:0050996) | 2.56558660 |
| 103 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.56107818 |
| 104 | serine family amino acid catabolic process (GO:0009071) | 2.55429616 |
| 105 | peptidyl-lysine trimethylation (GO:0018023) | 2.55399944 |
| 106 | cellular modified amino acid catabolic process (GO:0042219) | 2.55071019 |
| 107 | detection of other organism (GO:0098543) | 2.54422458 |
| 108 | regulation of macrophage cytokine production (GO:0010935) | 2.54343965 |
| 109 | positive regulation of fibroblast migration (GO:0010763) | 2.54018772 |
| 110 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.53128292 |
| 111 | neutrophil activation (GO:0042119) | 2.52435045 |
| 112 | cellular potassium ion homeostasis (GO:0030007) | 2.52091380 |
| 113 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.51403324 |
| 114 | 2-oxoglutarate metabolic process (GO:0006103) | 2.50835419 |
| 115 | complement activation, alternative pathway (GO:0006957) | 2.50171808 |
| 116 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.49648909 |
| 117 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.49516384 |
| 118 | NLS-bearing protein import into nucleus (GO:0006607) | 2.49412916 |
| 119 | phospholipid homeostasis (GO:0055091) | 2.49281479 |
| 120 | regulation of fibrinolysis (GO:0051917) | 2.47784291 |
| 121 | positive regulation of macrophage cytokine production (GO:0060907) | 2.47192751 |
| 122 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.47185711 |
| 123 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.46076094 |
| 124 | tryptophan metabolic process (GO:0006568) | 2.45056421 |
| 125 | establishment of nucleus localization (GO:0040023) | 2.44031013 |
| 126 | positive regulation of mast cell activation (GO:0033005) | 2.43421566 |
| 127 | high-density lipoprotein particle remodeling (GO:0034375) | 2.42766938 |
| 128 | cellular sodium ion homeostasis (GO:0006883) | 2.42301450 |
| 129 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.42277412 |
| 130 | regulation of mast cell activation (GO:0033003) | 2.42250241 |
| 131 | histone H3-K36 demethylation (GO:0070544) | 2.41534284 |
| 132 | myelin assembly (GO:0032288) | 2.41526521 |
| 133 | vesicle transport along microtubule (GO:0047496) | 2.40234353 |
| 134 | regulation of protein glycosylation (GO:0060049) | 2.40113227 |
| 135 | regulation of complement activation (GO:0030449) | 2.39997389 |
| 136 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.39454776 |
| 137 | protein K11-linked deubiquitination (GO:0035871) | 2.39194812 |
| 138 | regulation of RNA export from nucleus (GO:0046831) | 2.38909831 |
| 139 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.38813919 |
| 140 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.38431642 |
| 141 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.38115783 |
| 142 | import into cell (GO:0098657) | 2.37455281 |
| 143 | positive regulation of muscle hypertrophy (GO:0014742) | 2.36945752 |
| 144 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.36945752 |
| 145 | regulation of protein polyubiquitination (GO:1902914) | 2.36639784 |
| 146 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.36374073 |
| 147 | Golgi to endosome transport (GO:0006895) | 2.35479734 |
| 148 | COPII vesicle coating (GO:0048208) | 2.35076721 |
| 149 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.34443042 |
| 150 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.34290389 |
| 151 | negative regulation of cholesterol transport (GO:0032375) | 2.33169995 |
| 152 | negative regulation of sterol transport (GO:0032372) | 2.33169995 |
| 153 | clathrin coat assembly (GO:0048268) | 2.33160941 |
| 154 | protein-lipid complex assembly (GO:0065005) | 2.33055176 |
| 155 | epoxygenase P450 pathway (GO:0019373) | 2.32648433 |
| 156 | embryonic process involved in female pregnancy (GO:0060136) | 2.32234770 |
| 157 | negative regulation of B cell proliferation (GO:0030889) | 2.32188272 |
| 158 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.31798108 |
| 159 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.31481618 |
| 160 | positive regulation of glycolytic process (GO:0045821) | 2.31294642 |
| 161 | positive regulation of interferon-alpha production (GO:0032727) | 2.30606305 |
| 162 | layer formation in cerebral cortex (GO:0021819) | 2.30302628 |
| 163 | synaptic vesicle exocytosis (GO:0016079) | 2.30235529 |
| 164 | amino-acid betaine metabolic process (GO:0006577) | 2.29729864 |
| 165 | positive regulation of histone deacetylation (GO:0031065) | 2.29235361 |
| 166 | bile acid metabolic process (GO:0008206) | 2.29089011 |
| 167 | negative regulation of interleukin-17 production (GO:0032700) | 2.28422706 |
| 168 | cellular response to ethanol (GO:0071361) | 2.28076349 |
| 169 | peptidyl-threonine phosphorylation (GO:0018107) | 2.27327601 |
| 170 | negative regulation of sodium ion transport (GO:0010766) | 2.27306766 |
| 171 | histone H3-K4 trimethylation (GO:0080182) | 2.27238249 |
| 172 | negative regulation of cell size (GO:0045792) | 2.26494879 |
| 173 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.26322715 |
| 174 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.26197520 |
| 175 | plasma lipoprotein particle assembly (GO:0034377) | 2.25438573 |
| 176 | granulocyte activation (GO:0036230) | 2.25134489 |
| 177 | negative regulation of lipid transport (GO:0032369) | 2.24943017 |
| 178 | proline transport (GO:0015824) | 2.24200759 |
| 179 | endoplasmic reticulum organization (GO:0007029) | 2.23930653 |
| 180 | homocysteine metabolic process (GO:0050667) | 2.23682017 |
| 181 | negative regulation of protein activation cascade (GO:2000258) | 2.23225644 |
| 182 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.23149815 |
| 183 | dosage compensation (GO:0007549) | 2.23103836 |
| 184 | phospholipid translocation (GO:0045332) | 2.22609330 |
| 185 | lipid translocation (GO:0034204) | 2.22609330 |
| 186 | regulation of synaptic vesicle transport (GO:1902803) | 2.21998789 |
| 187 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.21993888 |
| 188 | Golgi transport vesicle coating (GO:0048200) | 2.21691219 |
| 189 | COPI coating of Golgi vesicle (GO:0048205) | 2.21691219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.05873535 |
| 2 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.97094613 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.93700636 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.93636668 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.68879523 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.54577442 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.46211790 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.44060408 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.37151407 |
| 10 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.01913805 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.99458564 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.98227201 |
| 13 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.91980483 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.91034515 |
| 15 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.90403552 |
| 16 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.87983911 |
| 17 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.80055733 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79407809 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79220743 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.76219237 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.73242334 |
| 22 | TP53_16413492_ChIP-PET_HCT116_Human | 1.73185612 |
| 23 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.71487128 |
| 24 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.69433267 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.67276324 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65508092 |
| 27 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.63204319 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.61427948 |
| 29 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.61310882 |
| 30 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.61089459 |
| 31 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59350080 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58837188 |
| 33 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.56853745 |
| 34 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.56751540 |
| 35 | FUS_26573619_Chip-Seq_HEK293_Human | 1.56613877 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55250148 |
| 37 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.55076072 |
| 38 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.54989096 |
| 39 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.52924284 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.52576950 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.52548668 |
| 42 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.52163343 |
| 43 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.52156007 |
| 44 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.48067521 |
| 45 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.47782807 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.47208489 |
| 47 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46496813 |
| 48 | * BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.46349732 |
| 49 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.44725442 |
| 50 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.44035252 |
| 51 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.43595612 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43306276 |
| 53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.41728390 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40960069 |
| 55 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.40440365 |
| 56 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.39727470 |
| 57 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.38525153 |
| 58 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38020777 |
| 59 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.36989656 |
| 60 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.36626146 |
| 61 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.33596454 |
| 62 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.32981983 |
| 63 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.32303483 |
| 64 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31959950 |
| 65 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.31845946 |
| 66 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31736181 |
| 67 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.31706974 |
| 68 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.31133950 |
| 69 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.31120715 |
| 70 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.30926716 |
| 71 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.30691623 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.28921452 |
| 73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.28667968 |
| 74 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.28286128 |
| 75 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.27815265 |
| 76 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.27287162 |
| 77 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.27181206 |
| 78 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.26319500 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25706680 |
| 80 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.25393909 |
| 81 | EWS_26573619_Chip-Seq_HEK293_Human | 1.25135491 |
| 82 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24867610 |
| 83 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.24034576 |
| 84 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23713406 |
| 85 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.22971504 |
| 86 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22546735 |
| 87 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.22013499 |
| 88 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.22013499 |
| 89 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.21945802 |
| 90 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21545764 |
| 91 | RXR_22108803_ChIP-Seq_LS180_Human | 1.21050587 |
| 92 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20657045 |
| 93 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.19918884 |
| 94 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18791969 |
| 95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18791969 |
| 96 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.18353435 |
| 97 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.16690817 |
| 98 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16524834 |
| 99 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.16094358 |
| 100 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.15687336 |
| 101 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.14729301 |
| 102 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.14304029 |
| 103 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14213962 |
| 104 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13466810 |
| 105 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13348064 |
| 106 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.13024598 |
| 107 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.12157326 |
| 108 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12001179 |
| 109 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.11760817 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 1.11444456 |
| 111 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.11109838 |
| 112 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10940617 |
| 113 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10567146 |
| 114 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10467573 |
| 115 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.10216892 |
| 116 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.10119056 |
| 117 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09892397 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09272078 |
| 119 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.08771800 |
| 120 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08270331 |
| 121 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.08081851 |
| 122 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.07945636 |
| 123 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07849635 |
| 124 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05097752 |
| 125 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.05027863 |
| 126 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.04757924 |
| 127 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04737489 |
| 128 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04102487 |
| 129 | AR_19668381_ChIP-Seq_PC3_Human | 1.04010958 |
| 130 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04002938 |
| 131 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.03277658 |
| 132 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.02624470 |
| 133 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02623877 |
| 134 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01231264 |
| 135 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01118137 |
| 136 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00816752 |
| 137 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.99822890 |
| 138 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99708046 |
| 139 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99058931 |
| 140 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.98652373 |
| 141 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97495194 |
| 142 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97208250 |
| 143 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96359310 |
| 144 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96267788 |
| 145 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.95116486 |
| 146 | TCF4_23295773_ChIP-Seq_U87_Human | 0.92158854 |
| 147 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92037505 |
| 148 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91852884 |
| 149 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.91572584 |
| 150 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.91310038 |
| 151 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90702144 |
| 152 | SPI1_23127762_ChIP-Seq_K562_Human | 0.90134071 |
| 153 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.89591693 |
| 154 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89565880 |
| 155 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88837688 |
| 156 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88694233 |
| 157 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88604214 |
| 158 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.88580665 |
| 159 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88297644 |
| 160 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.87279348 |
| 161 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86726126 |
| 162 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86680166 |
| 163 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86573063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.68577876 |
| 2 | MP0008057_abnormal_DNA_replication | 4.71231733 |
| 3 | MP0005360_urolithiasis | 4.25081896 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.95584381 |
| 5 | MP0005365_abnormal_bile_salt | 3.65698460 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 3.59036440 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.55462180 |
| 8 | MP0003300_gastrointestinal_ulcer | 3.02126686 |
| 9 | MP0003252_abnormal_bile_duct | 2.94680163 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.86592336 |
| 11 | MP0003221_abnormal_cardiomyocyte_apopto | 2.65893115 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.50948252 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.42704065 |
| 14 | MP0003724_increased_susceptibility_to | 2.42287951 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.40122477 |
| 16 | MP0005083_abnormal_biliary_tract | 2.39479293 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.32255943 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.26560020 |
| 19 | MP0008260_abnormal_autophagy | 2.16292217 |
| 20 | MP0008961_abnormal_basal_metabolism | 2.09626710 |
| 21 | MP0003329_amyloid_beta_deposits | 2.09318013 |
| 22 | MP0001835_abnormal_antigen_presentation | 2.02359286 |
| 23 | MP0000604_amyloidosis | 2.00993280 |
| 24 | MP0002909_abnormal_adrenal_gland | 1.91779669 |
| 25 | MP0003828_pulmonary_edema | 1.86890580 |
| 26 | MP0008877_abnormal_DNA_methylation | 1.84845498 |
| 27 | MP0002009_preneoplasia | 1.84599437 |
| 28 | MP0006054_spinal_hemorrhage | 1.83219144 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.80929008 |
| 30 | MP0003635_abnormal_synaptic_transmissio | 1.73027925 |
| 31 | MP0003890_abnormal_embryonic-extraembry | 1.72878040 |
| 32 | MP0005451_abnormal_body_composition | 1.69783107 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 1.62665641 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.57830268 |
| 35 | MP0002928_abnormal_bile_duct | 1.57563142 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.56469289 |
| 37 | MP0000015_abnormal_ear_pigmentation | 1.56028304 |
| 38 | MP0004270_analgesia | 1.52773382 |
| 39 | MP0002735_abnormal_chemical_nociception | 1.47442379 |
| 40 | MP0006082_CNS_inflammation | 1.46868232 |
| 41 | MP0001958_emphysema | 1.46274738 |
| 42 | MP0005332_abnormal_amino_acid | 1.46163139 |
| 43 | MP0002006_tumorigenesis | 1.46020242 |
| 44 | MP0002063_abnormal_learning/memory/cond | 1.45483386 |
| 45 | MP0002254_reproductive_system_inflammat | 1.42657714 |
| 46 | MP0003045_fibrosis | 1.40444450 |
| 47 | MP0002419_abnormal_innate_immunity | 1.40249924 |
| 48 | MP0000609_abnormal_liver_physiology | 1.39871182 |
| 49 | MP0003303_peritoneal_inflammation | 1.37895891 |
| 50 | MP0002118_abnormal_lipid_homeostasis | 1.34648620 |
| 51 | MP0002877_abnormal_melanocyte_morpholog | 1.32750404 |
| 52 | MP0000371_diluted_coat_color | 1.31247696 |
| 53 | MP0003091_abnormal_cell_migration | 1.31030656 |
| 54 | MP0005174_abnormal_tail_pigmentation | 1.30758068 |
| 55 | MP0005076_abnormal_cell_differentiation | 1.30222226 |
| 56 | MP0001968_abnormal_touch/_nociception | 1.28480002 |
| 57 | MP0001177_atelectasis | 1.23859246 |
| 58 | MP0001666_abnormal_nutrient_absorption | 1.22750060 |
| 59 | MP0004858_abnormal_nervous_system | 1.19026852 |
| 60 | MP0004130_abnormal_muscle_cell | 1.15429564 |
| 61 | MP0003195_calcinosis | 1.15082083 |
| 62 | MP0009840_abnormal_foam_cell | 1.13419375 |
| 63 | MP0005248_abnormal_Harderian_gland | 1.11607829 |
| 64 | MP0003787_abnormal_imprinting | 1.10273627 |
| 65 | MP0009745_abnormal_behavioral_response | 1.09448368 |
| 66 | MP0005319_abnormal_enzyme/_coenzyme | 1.08925194 |
| 67 | MP0001440_abnormal_grooming_behavior | 1.08599333 |
| 68 | MP0005408_hypopigmentation | 1.07784142 |
| 69 | MP0003868_abnormal_feces_composition | 1.06733904 |
| 70 | MP0005310_abnormal_salivary_gland | 1.03804170 |
| 71 | MP0001501_abnormal_sleep_pattern | 1.03005649 |
| 72 | MP0004484_altered_response_of | 1.02258275 |
| 73 | MP0003566_abnormal_cell_adhesion | 1.01017317 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 1.00101371 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 0.98482842 |
| 76 | MP0005621_abnormal_cell_physiology | 0.98120155 |
| 77 | MP0003690_abnormal_glial_cell | 0.97802857 |
| 78 | MP0001299_abnormal_eye_distance/ | 0.96393219 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 0.96118125 |
| 80 | MP0009785_altered_susceptibility_to | 0.95561725 |
| 81 | MP0001800_abnormal_humoral_immune | 0.94189122 |
| 82 | MP0002090_abnormal_vision | 0.93938559 |
| 83 | MP0002168_other_aberrant_phenotype | 0.92634029 |
| 84 | MP0001765_abnormal_ion_homeostasis | 0.92604073 |
| 85 | MP0008874_decreased_physiological_sensi | 0.92095386 |
| 86 | MP0004811_abnormal_neuron_physiology | 0.91915377 |
| 87 | MP0005058_abnormal_lysosome_morphology | 0.90825978 |
| 88 | MP0005000_abnormal_immune_tolerance | 0.90810501 |
| 89 | MP0010307_abnormal_tumor_latency | 0.90710988 |
| 90 | MP0002396_abnormal_hematopoietic_system | 0.90577783 |
| 91 | MP0003172_abnormal_lysosome_physiology | 0.89179452 |
| 92 | MP0005166_decreased_susceptibility_to | 0.88214302 |
| 93 | MP0000516_abnormal_urinary_system | 0.87238756 |
| 94 | MP0005367_renal/urinary_system_phenotyp | 0.87238756 |
| 95 | MP0001915_intracranial_hemorrhage | 0.87051354 |
| 96 | MP0005266_abnormal_metabolism | 0.86936574 |
| 97 | MP0002452_abnormal_antigen_presenting | 0.86325604 |
| 98 | MP0002064_seizures | 0.85322551 |
| 99 | MP0002723_abnormal_immune_serum | 0.84876882 |
| 100 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84526567 |
| 101 | MP0002736_abnormal_nociception_after | 0.83645105 |
| 102 | MP0004233_abnormal_muscle_weight | 0.83379065 |
| 103 | MP0001851_eye_inflammation | 0.81973858 |
| 104 | MP0003075_altered_response_to | 0.81966044 |
| 105 | MP0003633_abnormal_nervous_system | 0.81957415 |
| 106 | MP0005647_abnormal_sex_gland | 0.81745831 |
| 107 | MP0002166_altered_tumor_susceptibility | 0.81025395 |
| 108 | MP0000598_abnormal_liver_morphology | 0.79976116 |
| 109 | MP0009046_muscle_twitch | 0.79961768 |
| 110 | MP0010678_abnormal_skin_adnexa | 0.79711274 |
| 111 | MP0004883_abnormal_blood_vessel | 0.78732798 |
| 112 | MP0002089_abnormal_postnatal_growth/wei | 0.77954591 |
| 113 | MP0003656_abnormal_erythrocyte_physiolo | 0.77021892 |
| 114 | MP0003448_altered_tumor_morphology | 0.76827825 |
| 115 | MP0002572_abnormal_emotion/affect_behav | 0.75930954 |
| 116 | MP0004510_myositis | 0.75471492 |
| 117 | MP0000920_abnormal_myelination | 0.74472693 |
| 118 | MP0005023_abnormal_wound_healing | 0.74426801 |
| 119 | MP0005535_abnormal_body_temperature | 0.74365332 |
| 120 | MP0005084_abnormal_gallbladder_morpholo | 0.74302460 |
| 121 | MP0004134_abnormal_chest_morphology | 0.73652452 |
| 122 | MP0001756_abnormal_urination | 0.72618354 |
| 123 | MP0002733_abnormal_thermal_nociception | 0.72583537 |
| 124 | MP0005384_cellular_phenotype | 0.72364331 |
| 125 | MP0005395_other_phenotype | 0.71493492 |
| 126 | MP0002420_abnormal_adaptive_immunity | 0.71083591 |
| 127 | MP0001819_abnormal_immune_cell | 0.70373265 |
| 128 | MP0002822_catalepsy | 0.68919722 |
| 129 | MP0001845_abnormal_inflammatory_respons | 0.68307968 |
| 130 | MP0004019_abnormal_vitamin_homeostasis | 0.68277414 |
| 131 | MP0010368_abnormal_lymphatic_system | 0.67231050 |
| 132 | MP0004185_abnormal_adipocyte_glucose | 0.65394193 |
| 133 | MP0008004_abnormal_stomach_pH | 0.65215481 |
| 134 | MP0000465_gastrointestinal_hemorrhage | 0.65043288 |
| 135 | MP0005334_abnormal_fat_pad | 0.64878380 |
| 136 | MP0002398_abnormal_bone_marrow | 0.64540082 |
| 137 | MP0005464_abnormal_platelet_physiology | 0.63834831 |
| 138 | MP0009115_abnormal_fat_cell | 0.63751746 |
| 139 | MP0002269_muscular_atrophy | 0.63676378 |
| 140 | MP0000689_abnormal_spleen_morphology | 0.63481281 |
| 141 | MP0005397_hematopoietic_system_phenotyp | 0.63451715 |
| 142 | MP0001545_abnormal_hematopoietic_system | 0.63451715 |
| 143 | MP0002078_abnormal_glucose_homeostasis | 0.63116646 |
| 144 | MP0003436_decreased_susceptibility_to | 0.62916544 |
| 145 | MP0009763_increased_sensitivity_to | 0.62716704 |
| 146 | MP0009643_abnormal_urine_homeostasis | 0.62516581 |
| 147 | MP0004947_skin_inflammation | 0.62507477 |
| 148 | MP0001881_abnormal_mammary_gland | 0.62260526 |
| 149 | MP0000427_abnormal_hair_cycle | 0.61895415 |
| 150 | MP0001533_abnormal_skeleton_physiology | 0.61756282 |
| 151 | MP0004264_abnormal_extraembryonic_tissu | 0.60766040 |
| 152 | MP0003806_abnormal_nucleotide_metabolis | 0.60566221 |
| 153 | MP0009764_decreased_sensitivity_to | 0.58761871 |
| 154 | MP0009697_abnormal_copulation | 0.56687792 |
| 155 | MP0002734_abnormal_mechanical_nocicepti | 0.56033611 |
| 156 | MP0002896_abnormal_bone_mineralization | 0.55856322 |
| 157 | MP0004782_abnormal_surfactant_physiolog | 0.55815708 |
| 158 | MP0004885_abnormal_endolymph | 0.55339297 |
| 159 | MP0002998_abnormal_bone_remodeling | 0.55257437 |
| 160 | MP0003631_nervous_system_phenotype | 0.54476149 |
| 161 | MP0005164_abnormal_response_to | 0.54318600 |
| 162 | MP0000013_abnormal_adipose_tissue | 0.53937604 |
| 163 | MP0009384_cardiac_valve_regurgitation | 0.53153494 |
| 164 | MP0005666_abnormal_adipose_tissue | 0.51010529 |
| 165 | MP0009672_abnormal_birth_weight | 0.50430239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papillary thyroid carcinoma (HP:0002895) | 4.56710219 |
| 2 | Fair hair (HP:0002286) | 3.62894043 |
| 3 | Deep venous thrombosis (HP:0002625) | 3.59582697 |
| 4 | Long clavicles (HP:0000890) | 3.14072861 |
| 5 | Volvulus (HP:0002580) | 3.11123577 |
| 6 | Thyroid carcinoma (HP:0002890) | 3.07406033 |
| 7 | Abnormality of the lower motor neuron (HP:0002366) | 3.01230992 |
| 8 | Medulloblastoma (HP:0002885) | 2.95299755 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 2.90877495 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 2.90584193 |
| 11 | Generalized hypopigmentation of hair (HP:0011358) | 2.87504204 |
| 12 | Xanthomatosis (HP:0000991) | 2.86783148 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.83406094 |
| 14 | Absent frontal sinuses (HP:0002688) | 2.77266096 |
| 15 | Dysmetric saccades (HP:0000641) | 2.75707975 |
| 16 | Gout (HP:0001997) | 2.74840475 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 2.70588746 |
| 18 | Gingival bleeding (HP:0000225) | 2.69661518 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 2.62437458 |
| 20 | Optic neuritis (HP:0100653) | 2.62437458 |
| 21 | Aortic aneurysm (HP:0004942) | 2.59943618 |
| 22 | Macroorchidism (HP:0000053) | 2.54654995 |
| 23 | Abnormality of the labia minora (HP:0012880) | 2.51623196 |
| 24 | Abnormal hair whorl (HP:0010721) | 2.51171797 |
| 25 | Long toe (HP:0010511) | 2.50022803 |
| 26 | Hypobetalipoproteinemia (HP:0003563) | 2.49741094 |
| 27 | Recurrent abscess formation (HP:0002722) | 2.49447044 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.46018067 |
| 29 | Inappropriate behavior (HP:0000719) | 2.45980434 |
| 30 | Focal seizures (HP:0007359) | 2.45283631 |
| 31 | T lymphocytopenia (HP:0005403) | 2.44514450 |
| 32 | Curly hair (HP:0002212) | 2.42901614 |
| 33 | Focal motor seizures (HP:0011153) | 2.40288097 |
| 34 | Global brain atrophy (HP:0002283) | 2.39867845 |
| 35 | Disinhibition (HP:0000734) | 2.38522064 |
| 36 | Skin nodule (HP:0200036) | 2.37628576 |
| 37 | Febrile seizures (HP:0002373) | 2.36824150 |
| 38 | Papilledema (HP:0001085) | 2.35461337 |
| 39 | Action tremor (HP:0002345) | 2.34912197 |
| 40 | Abnormal social behavior (HP:0012433) | 2.34560132 |
| 41 | Impaired social interactions (HP:0000735) | 2.34560132 |
| 42 | Amyotrophic lateral sclerosis (HP:0007354) | 2.31911517 |
| 43 | Mitral stenosis (HP:0001718) | 2.31620832 |
| 44 | Lower limb hyperreflexia (HP:0002395) | 2.31358587 |
| 45 | Periodontitis (HP:0000704) | 2.31057027 |
| 46 | Hepatoblastoma (HP:0002884) | 2.29541067 |
| 47 | Abnormality of T cell number (HP:0011839) | 2.28769473 |
| 48 | Hyperlipoproteinemia (HP:0010980) | 2.28329544 |
| 49 | Acute myeloid leukemia (HP:0004808) | 2.25594633 |
| 50 | Autoamputation (HP:0001218) | 2.22310925 |
| 51 | Epidermoid cyst (HP:0200040) | 2.20911047 |
| 52 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.20402322 |
| 53 | Orchitis (HP:0100796) | 2.15884000 |
| 54 | Genetic anticipation (HP:0003743) | 2.14063780 |
| 55 | Arterial thrombosis (HP:0004420) | 2.12721595 |
| 56 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.12592808 |
| 57 | Short 1st metacarpal (HP:0010034) | 2.12592808 |
| 58 | Mitral valve prolapse (HP:0001634) | 2.11887187 |
| 59 | Complement deficiency (HP:0004431) | 2.10934431 |
| 60 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.09733338 |
| 61 | Hypolipoproteinemia (HP:0010981) | 2.08802539 |
| 62 | Hypoalphalipoproteinemia (HP:0003233) | 2.08624502 |
| 63 | Hyperventilation (HP:0002883) | 2.07863152 |
| 64 | Aneurysm (HP:0002617) | 2.05147670 |
| 65 | Myocardial infarction (HP:0001658) | 2.04586235 |
| 66 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.04562690 |
| 67 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.04562690 |
| 68 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.02881103 |
| 69 | Sensorimotor neuropathy (HP:0007141) | 2.02302679 |
| 70 | Status epilepticus (HP:0002133) | 2.01583045 |
| 71 | Progressive inability to walk (HP:0002505) | 1.99237221 |
| 72 | Fatigue (HP:0012378) | 1.98478331 |
| 73 | Facial diplegia (HP:0001349) | 1.98455881 |
| 74 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.97607852 |
| 75 | Cystic hygroma (HP:0000476) | 1.97116250 |
| 76 | Deep philtrum (HP:0002002) | 1.96984006 |
| 77 | Cerebral aneurysm (HP:0004944) | 1.96064871 |
| 78 | Truncal obesity (HP:0001956) | 1.95856237 |
| 79 | Resting tremor (HP:0002322) | 1.95085561 |
| 80 | Progressive cerebellar ataxia (HP:0002073) | 1.94958044 |
| 81 | Increased mean platelet volume (HP:0011877) | 1.94948546 |
| 82 | Abnormality of purine metabolism (HP:0004352) | 1.94819086 |
| 83 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.92926607 |
| 84 | Agnosia (HP:0010524) | 1.92890480 |
| 85 | Heterotopia (HP:0002282) | 1.92563934 |
| 86 | Impaired smooth pursuit (HP:0007772) | 1.91823890 |
| 87 | Hypoplastic labia majora (HP:0000059) | 1.90351879 |
| 88 | Abnormality of the Achilles tendon (HP:0005109) | 1.89149178 |
| 89 | Upper limb amyotrophy (HP:0009129) | 1.88342760 |
| 90 | Distal upper limb amyotrophy (HP:0007149) | 1.88342760 |
| 91 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86749087 |
| 92 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.86388778 |
| 93 | Increased density of long bones (HP:0006392) | 1.85473487 |
| 94 | Tetraparesis (HP:0002273) | 1.85425635 |
| 95 | Ketosis (HP:0001946) | 1.85197818 |
| 96 | Impaired vibratory sensation (HP:0002495) | 1.84851591 |
| 97 | Keratoconjunctivitis sicca (HP:0001097) | 1.84625832 |
| 98 | Narrow palate (HP:0000189) | 1.84280758 |
| 99 | Hand muscle atrophy (HP:0009130) | 1.83934791 |
| 100 | Broad ribs (HP:0000885) | 1.82989885 |
| 101 | Scanning speech (HP:0002168) | 1.82790725 |
| 102 | Arterial tortuosity (HP:0005116) | 1.82351125 |
| 103 | Prominent nose (HP:0000448) | 1.81266109 |
| 104 | Hypercholesterolemia (HP:0003124) | 1.81260950 |
| 105 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.81131941 |
| 106 | Lower limb muscle weakness (HP:0007340) | 1.80886009 |
| 107 | Prolonged partial thromboplastin time (HP:0003645) | 1.80275321 |
| 108 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.80252377 |
| 109 | Striae distensae (HP:0001065) | 1.80208018 |
| 110 | Keratoconjunctivitis (HP:0001096) | 1.79611094 |
| 111 | Myositis (HP:0100614) | 1.79555326 |
| 112 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.78736249 |
| 113 | Excessive salivation (HP:0003781) | 1.78695741 |
| 114 | Drooling (HP:0002307) | 1.78695741 |
| 115 | Poor eye contact (HP:0000817) | 1.78624031 |
| 116 | Short phalanx of the thumb (HP:0009660) | 1.78491436 |
| 117 | Hypochromic microcytic anemia (HP:0004840) | 1.78398630 |
| 118 | Gingivitis (HP:0000230) | 1.77555966 |
| 119 | Submucous cleft hard palate (HP:0000176) | 1.77278754 |
| 120 | Conjunctival telangiectasia (HP:0000524) | 1.77230686 |
| 121 | Acanthocytosis (HP:0001927) | 1.76467899 |
| 122 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.76425165 |
| 123 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.76425165 |
| 124 | Spondylolisthesis (HP:0003302) | 1.76177656 |
| 125 | Atonic seizures (HP:0010819) | 1.75759473 |
| 126 | Subaortic stenosis (HP:0001682) | 1.75631294 |
| 127 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.75631294 |
| 128 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.75573466 |
| 129 | Urinary urgency (HP:0000012) | 1.74999105 |
| 130 | Subacute progressive viral hepatitis (HP:0006572) | 1.74639231 |
| 131 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.74598862 |
| 132 | Pelvic girdle muscle weakness (HP:0003749) | 1.74283648 |
| 133 | Hemiplegia (HP:0002301) | 1.74053941 |
| 134 | Aqueductal stenosis (HP:0002410) | 1.73978090 |
| 135 | Rhabdomyosarcoma (HP:0002859) | 1.73910589 |
| 136 | Postural instability (HP:0002172) | 1.73591401 |
| 137 | Spontaneous abortion (HP:0005268) | 1.72565553 |
| 138 | Hydroxyprolinuria (HP:0003080) | 1.72223568 |
| 139 | Abnormality of proline metabolism (HP:0010907) | 1.72223568 |
| 140 | Dilatation of the ascending aorta (HP:0005111) | 1.71934579 |
| 141 | Eczematoid dermatitis (HP:0000976) | 1.71783404 |
| 142 | Myokymia (HP:0002411) | 1.71382173 |
| 143 | Protuberant abdomen (HP:0001538) | 1.71295137 |
| 144 | Spontaneous hematomas (HP:0007420) | 1.71279377 |
| 145 | Abnormality of the intrinsic pathway (HP:0010989) | 1.70886622 |
| 146 | Absent speech (HP:0001344) | 1.70711482 |
| 147 | Bladder carcinoma (HP:0002862) | 1.70078251 |
| 148 | Bladder neoplasm (HP:0009725) | 1.70078251 |
| 149 | Stomatitis (HP:0010280) | 1.70077160 |
| 150 | Abnormality of the 1st metacarpal (HP:0010009) | 1.69669242 |
| 151 | Widely spaced teeth (HP:0000687) | 1.69447672 |
| 152 | Rectal prolapse (HP:0002035) | 1.69397969 |
| 153 | Abnormality of the labia majora (HP:0012881) | 1.68912231 |
| 154 | Protruding tongue (HP:0010808) | 1.68449011 |
| 155 | Menstrual irregularities (HP:0000858) | 1.68054037 |
| 156 | Difficulty running (HP:0009046) | 1.67790989 |
| 157 | Decreased skull ossification (HP:0004331) | 1.67702238 |
| 158 | Absence seizures (HP:0002121) | 1.67104941 |
| 159 | Insidious onset (HP:0003587) | 1.66871049 |
| 160 | Termporal pattern (HP:0011008) | 1.66871049 |
| 161 | Visual hallucinations (HP:0002367) | 1.65952817 |
| 162 | Abnormal platelet volume (HP:0011876) | 1.65605492 |
| 163 | Relative macrocephaly (HP:0004482) | 1.65220150 |
| 164 | Hyperuricemia (HP:0002149) | 1.64940843 |
| 165 | Increased purine levels (HP:0004368) | 1.64940843 |
| 166 | Lymphangioma (HP:0100764) | 1.64243893 |
| 167 | Frequent falls (HP:0002359) | 1.64157826 |
| 168 | Pulmonary embolism (HP:0002204) | 1.62440968 |
| 169 | Vascular tortuosity (HP:0004948) | 1.62099385 |
| 170 | Neonatal onset (HP:0003623) | 1.61372931 |
| 171 | Obsessive-compulsive behavior (HP:0000722) | 1.61217803 |
| 172 | Joint hemorrhage (HP:0005261) | 1.60397794 |
| 173 | Enlarged penis (HP:0000040) | 1.57364920 |
| 174 | Spinal cord lesions (HP:0100561) | 1.57177880 |
| 175 | Syringomyelia (HP:0003396) | 1.57177880 |
| 176 | Esophageal varix (HP:0002040) | 1.56327942 |
| 177 | Abnormality of the thoracic spine (HP:0100711) | 1.55969128 |
| 178 | Achilles tendon contracture (HP:0001771) | 1.55515033 |
| 179 | Gaze-evoked nystagmus (HP:0000640) | 1.55506615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.46954018 |
| 2 | PINK1 | 3.29342004 |
| 3 | ACVR1B | 2.85798770 |
| 4 | AKT3 | 2.76969045 |
| 5 | EIF2AK3 | 2.75557741 |
| 6 | RIPK4 | 2.46614797 |
| 7 | FRK | 2.35968921 |
| 8 | NTRK3 | 2.26652820 |
| 9 | LMTK2 | 2.24474001 |
| 10 | BMPR2 | 2.24255566 |
| 11 | TRIM28 | 2.18675877 |
| 12 | CAMK1G | 2.09628071 |
| 13 | MAP3K4 | 2.06815094 |
| 14 | RIPK1 | 2.01385237 |
| 15 | ERBB3 | 2.00238192 |
| 16 | DAPK2 | 1.93247005 |
| 17 | TAOK3 | 1.90571933 |
| 18 | FGFR2 | 1.85123749 |
| 19 | CAMK1D | 1.84312008 |
| 20 | BCR | 1.76844598 |
| 21 | SCYL2 | 1.75668217 |
| 22 | KSR2 | 1.75466814 |
| 23 | CAMKK1 | 1.74099917 |
| 24 | TRIB3 | 1.72960474 |
| 25 | MAP2K4 | 1.71774081 |
| 26 | FGFR4 | 1.71103826 |
| 27 | PKN2 | 1.68313208 |
| 28 | MAP4K2 | 1.67725783 |
| 29 | EPHA4 | 1.64604150 |
| 30 | MINK1 | 1.63525776 |
| 31 | KSR1 | 1.62649328 |
| 32 | TAOK1 | 1.60746014 |
| 33 | CAMKK2 | 1.60489860 |
| 34 | PRKD3 | 1.53673490 |
| 35 | STK3 | 1.52250191 |
| 36 | BLK | 1.47272237 |
| 37 | STK38 | 1.45773433 |
| 38 | IRAK1 | 1.43331059 |
| 39 | YES1 | 1.41996679 |
| 40 | RET | 1.40923426 |
| 41 | MAP3K14 | 1.40636408 |
| 42 | SGK3 | 1.38634523 |
| 43 | IRAK2 | 1.37292312 |
| 44 | CDK6 | 1.34370383 |
| 45 | FGFR3 | 1.33888105 |
| 46 | PDGFRA | 1.32019786 |
| 47 | TNIK | 1.28809992 |
| 48 | BRD4 | 1.28385258 |
| 49 | MAP3K2 | 1.27810052 |
| 50 | SIK3 | 1.26085077 |
| 51 | SIK1 | 1.25906654 |
| 52 | PTK2B | 1.24929713 |
| 53 | FGR | 1.20352423 |
| 54 | NTRK1 | 1.19063396 |
| 55 | MAP3K13 | 1.18795035 |
| 56 | MAP3K6 | 1.12571641 |
| 57 | DMPK | 1.11887238 |
| 58 | TYK2 | 1.10232773 |
| 59 | MAP3K7 | 1.08942123 |
| 60 | PTK2 | 1.08461002 |
| 61 | MAP3K12 | 1.07954301 |
| 62 | LATS1 | 1.07343526 |
| 63 | SGK494 | 1.07287233 |
| 64 | SGK223 | 1.07287233 |
| 65 | PBK | 1.04548944 |
| 66 | PAK6 | 1.00839992 |
| 67 | EIF2AK1 | 1.00322354 |
| 68 | LATS2 | 0.97931472 |
| 69 | PDGFRB | 0.97714329 |
| 70 | NEK6 | 0.97579484 |
| 71 | JAK1 | 0.97512749 |
| 72 | FGFR1 | 0.97084815 |
| 73 | TRPM7 | 0.96404789 |
| 74 | STK24 | 0.91953865 |
| 75 | MAP2K3 | 0.91356133 |
| 76 | SGK2 | 0.90834058 |
| 77 | PDK1 | 0.89449926 |
| 78 | FER | 0.89103507 |
| 79 | SIK2 | 0.89033157 |
| 80 | PTK6 | 0.88141464 |
| 81 | ERN1 | 0.86045236 |
| 82 | MST4 | 0.85501787 |
| 83 | NLK | 0.85443278 |
| 84 | EEF2K | 0.85386680 |
| 85 | DAPK1 | 0.84289303 |
| 86 | TESK1 | 0.83483105 |
| 87 | TEC | 0.83083128 |
| 88 | TTN | 0.80805031 |
| 89 | PNCK | 0.78245041 |
| 90 | PRKCH | 0.78023109 |
| 91 | ALK | 0.77382426 |
| 92 | OBSCN | 0.77365919 |
| 93 | MAPK13 | 0.76522080 |
| 94 | MAP3K3 | 0.75183828 |
| 95 | TYRO3 | 0.72996936 |
| 96 | CDK12 | 0.72873872 |
| 97 | PDK4 | 0.72656287 |
| 98 | PDK3 | 0.72656287 |
| 99 | BRSK2 | 0.72258480 |
| 100 | TGFBR2 | 0.71887205 |
| 101 | CDK5 | 0.69491728 |
| 102 | PAK3 | 0.69205405 |
| 103 | MTOR | 0.69130734 |
| 104 | PDPK1 | 0.68861794 |
| 105 | NEK1 | 0.68610762 |
| 106 | STK38L | 0.67085299 |
| 107 | CSK | 0.66668141 |
| 108 | MAP3K5 | 0.66514402 |
| 109 | MAP2K7 | 0.65991593 |
| 110 | WNK3 | 0.65976060 |
| 111 | PLK2 | 0.63606302 |
| 112 | MARK3 | 0.63457055 |
| 113 | RAF1 | 0.63445172 |
| 114 | DYRK3 | 0.63168395 |
| 115 | MAP3K1 | 0.62505241 |
| 116 | HCK | 0.61545258 |
| 117 | LRRK2 | 0.60267998 |
| 118 | JAK2 | 0.59627724 |
| 119 | IKBKE | 0.59411634 |
| 120 | IRAK4 | 0.58680036 |
| 121 | INSRR | 0.58269000 |
| 122 | WNK1 | 0.57479269 |
| 123 | ZAP70 | 0.54496142 |
| 124 | RPS6KA4 | 0.53140143 |
| 125 | STK10 | 0.52391026 |
| 126 | CLK1 | 0.50933805 |
| 127 | TSSK6 | 0.50074107 |
| 128 | STK11 | 0.49685750 |
| 129 | ITK | 0.48829991 |
| 130 | PIK3CG | 0.47538966 |
| 131 | PRKAA2 | 0.47048053 |
| 132 | GRK6 | 0.47035623 |
| 133 | FYN | 0.46922020 |
| 134 | MELK | 0.46736321 |
| 135 | CSNK1A1L | 0.44643445 |
| 136 | SGK1 | 0.43968522 |
| 137 | PIM1 | 0.40870544 |
| 138 | EGFR | 0.40556882 |
| 139 | SRPK1 | 0.40182513 |
| 140 | CCNB1 | 0.39156174 |
| 141 | PRKCQ | 0.38964490 |
| 142 | SYK | 0.38803101 |
| 143 | MAPK10 | 0.38794283 |
| 144 | STK4 | 0.38415483 |
| 145 | DDR2 | 0.38372482 |
| 146 | EPHA3 | 0.38108189 |
| 147 | PRKCG | 0.38048656 |
| 148 | BRAF | 0.37316011 |
| 149 | TNK2 | 0.37220318 |
| 150 | CAMK1 | 0.36939372 |
| 151 | NEK9 | 0.35815766 |
| 152 | EIF2AK2 | 0.35385077 |
| 153 | JAK3 | 0.34770646 |
| 154 | FES | 0.34166265 |
| 155 | PRKCE | 0.33937974 |
| 156 | PRKG2 | 0.33936044 |
| 157 | CAMK4 | 0.32910556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.62678661 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.67478881 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.27187912 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.16522005 |
| 5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.05447000 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.91945394 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 1.82363551 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.78837408 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68549592 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 1.63825907 |
| 11 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61978921 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 1.61776661 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 1.61404785 |
| 14 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.57088819 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.54874116 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.48351754 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.40484680 |
| 18 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.40372424 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.38766103 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34744528 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.29674857 |
| 22 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.29469971 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.26281222 |
| 24 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.22428013 |
| 25 | Hepatitis B_Homo sapiens_hsa05161 | 1.21189113 |
| 26 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.21161424 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.15400874 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14274462 |
| 29 | Glioma_Homo sapiens_hsa05214 | 1.14263605 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13327532 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.12307799 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10459555 |
| 33 | Prostate cancer_Homo sapiens_hsa05215 | 1.10174307 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.10095703 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09007704 |
| 36 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.08128654 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05715665 |
| 38 | Salivary secretion_Homo sapiens_hsa04970 | 1.05112609 |
| 39 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.04664848 |
| 40 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.04654718 |
| 41 | Circadian rhythm_Homo sapiens_hsa04710 | 1.04009752 |
| 42 | Nicotine addiction_Homo sapiens_hsa05033 | 1.03576940 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.02754722 |
| 44 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02599698 |
| 45 | Colorectal cancer_Homo sapiens_hsa05210 | 1.02572303 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02339742 |
| 47 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.02199543 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.01784219 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01646202 |
| 50 | Circadian entrainment_Homo sapiens_hsa04713 | 1.01591209 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.01367961 |
| 52 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.99338585 |
| 53 | Renin secretion_Homo sapiens_hsa04924 | 0.98446997 |
| 54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.97330233 |
| 55 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.96430122 |
| 56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93291521 |
| 57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93193248 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 0.92579190 |
| 59 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.92360993 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.91426097 |
| 61 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90504704 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.89441028 |
| 63 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87791004 |
| 64 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.87612090 |
| 65 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.86910176 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86611858 |
| 67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85956358 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.85761759 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.85464637 |
| 70 | Olfactory transduction_Homo sapiens_hsa04740 | 0.83810065 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83607112 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.83109070 |
| 73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.81569410 |
| 74 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.80856288 |
| 75 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.77113085 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.76389405 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76132712 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75692862 |
| 79 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75347239 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74610172 |
| 81 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.74545090 |
| 82 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74323690 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74100794 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73943636 |
| 85 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.73126968 |
| 86 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.71675876 |
| 87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71335004 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70281049 |
| 89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69408119 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69373474 |
| 91 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68850336 |
| 92 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.68840348 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.68302005 |
| 94 | GABAergic synapse_Homo sapiens_hsa04727 | 0.68100911 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67678295 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67278887 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67261979 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66904072 |
| 99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66184855 |
| 100 | Morphine addiction_Homo sapiens_hsa05032 | 0.66133012 |
| 101 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.66071237 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64829299 |
| 103 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.64700942 |
| 104 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64699589 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64660087 |
| 106 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64655884 |
| 107 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64567898 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64393793 |
| 109 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63084116 |
| 110 | Shigellosis_Homo sapiens_hsa05131 | 0.62929353 |
| 111 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.62603052 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62086430 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62015154 |
| 114 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.61656780 |
| 115 | Long-term depression_Homo sapiens_hsa04730 | 0.61609805 |
| 116 | Salmonella infection_Homo sapiens_hsa05132 | 0.61473999 |
| 117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60399366 |
| 118 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59593955 |
| 119 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.59560883 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59546051 |
| 121 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59423793 |
| 122 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59029717 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57724142 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57112479 |
| 125 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57043538 |
| 126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56813289 |
| 127 | Gap junction_Homo sapiens_hsa04540 | 0.56411115 |
| 128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56211480 |
| 129 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.55885208 |
| 130 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55366857 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54904296 |
| 132 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54754136 |
| 133 | Alcoholism_Homo sapiens_hsa05034 | 0.54428160 |
| 134 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.53761897 |
| 135 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.53416771 |
| 136 | Pertussis_Homo sapiens_hsa05133 | 0.53075514 |
| 137 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53045024 |
| 138 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52739127 |
| 139 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52590986 |
| 140 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52445791 |
| 141 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52013372 |
| 142 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.51675026 |
| 143 | Peroxisome_Homo sapiens_hsa04146 | 0.50965932 |
| 144 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50769299 |
| 145 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50446177 |
| 146 | Melanoma_Homo sapiens_hsa05218 | 0.50208904 |
| 147 | Focal adhesion_Homo sapiens_hsa04510 | 0.49711638 |
| 148 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49647568 |
| 149 | Amoebiasis_Homo sapiens_hsa05146 | 0.49504775 |
| 150 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48990098 |
| 151 | Platelet activation_Homo sapiens_hsa04611 | 0.48972403 |
| 152 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.48791669 |
| 153 | Adherens junction_Homo sapiens_hsa04520 | 0.48767943 |
| 154 | Malaria_Homo sapiens_hsa05144 | 0.48032167 |
| 155 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47969523 |
| 156 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47682377 |
| 157 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47566978 |
| 158 | Endocytosis_Homo sapiens_hsa04144 | 0.45794964 |

